AVR 0.00% $18.00 anteris technologies ltd

Great post. We noted many of the same highlights. There are...

  1. 3,092 Posts.
    lightbulb Created with Sketch. 69
    Great post. We noted many of the same highlights.

    There are currently many 'halo' effects going on with numerous efforts within the company....

    i) The excellence of Ademedus's work with the RAH is being noticed by many other hospitals with upcoming tenders....

    ii) The uniqueness of CardioCel 3D is having an effect on surgeons trialing 3D wanting to use other ADAPT products.

    iii) The recently signed deal with 4C will have a big impact on other device makers, particularly the big 4. Whilst 4C doesn't have a product on market yet their ingenious and game changing design is recognised within the TMVR field as having a massive future and they having chosen ADAPT and Admedus after months of negotiation is, what Wayne hesitantly called an 'inflection point.' He believes that many will look back on this moment in our history as something very very special.

    iv) The TAVR device is a thing of beauty, who will our partner be?

    v) The CardioCel 3D marketing campaign, to appear in leading cardiovascular journals in the coming months is a thing of genius. Whoever came up with this well done!
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.